Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blue Earth Diagnostics, Canhelp Genomics, Hyperfine, Renovorx.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bioporto, Bivacor, Bracco, Burl Concepts, Cortechs.ai, Ilof, Jellox, Matrix Surgical, Mayo Clinic, Molli Surgical, Nervonik, Stryker.
The $80 million in financing that Huma Therapeutics Ltd. recently raised is a testament to where the company is and what it achieved at a time when the digital health industry is struggling to raise significant financing, Mert Aral, chief medical officer at Huma, told BioWorld.
Sunbird Bio Inc.’s Neural EV-tau aggregate assay demonstrated 92% correlation with PET scans in identifying individuals with Alzheimer’s disease, a study presented at the Alzheimer’s Association International Conference in Philadelphia, on July 30 found.
The U.S. CMS proposed a series of changes to the Medicare series of codes for diagnostic-related groups, and device makers had pointed remarks about some of those proposals.
The U.S. FDA proposed to overhaul guidances for maxillofacial systems that accumulated at least 18 years' of dust, in an effort to keep up to date with modern medical technology.